Response to BRAF Inhibition in Melanoma Is Enhanced When Combined with Immune Checkpoint BlockadeZachary A. Cooper(AstraZeneca (Singapore)), Jennifer A. Wargo(The University of Texas MD Anderson Cancer Center)Cancer Immunology ResearchApril 29, 201410.1158/2326-6066.cir-13-0215Cited by 257SaveCiteExport RISWatch citationsRelated PapersGut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients|Science|2017|4.6kB cells and tertiary lymphoid structures promote immunotherapy response|Nature|2020|2.6kDefining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma|Cell|2018|2kPotential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine|Science|2017|1.8kTumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion|Nature|2012|1.7k